Essential cross-linking role for FcgRIIB in the in vivo activity of anti-CD40 monoclonal antibody

被引：0
|
作者：
White, A. L. [1 ]
Chan, H. T. C. [1 ]
French, R. R. [1 ]
Roghanian, A. [1 ]
Mockridge, C. I. [1 ]
Tutt, A. L. [1 ]
Verbeek, J. S. [2 ]
Noelle, R. J. [3 ]
Al-Shamkhani, A. [1 ]
Cragg, M. S. [1 ]
Beers, S. A. [1 ]
Glennie, M. J. [1 ]
机构：
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Kings Coll London, MRC, Ctr Transplantat, London WC2R 2LS, England
来源：
IMMUNOLOGY | 2011年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [31] Affinity and epitope profiling of mouse anti-CD40 monoclonal antibodies
    Hager, ACM
    Ellmark, P
    Borrebaeck, CAK
    Furebring, C
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (06) : 517 - 524
  • [32] Dacetuzumab (SGN-40), a humanized anti-CD40 monoclonal antibody, has chemosensitization activity and improves gemcitabine efficacy in NHL xenograft models
    Lewis, Timothy
    McCormick, Renee
    Stone, Ivan
    Gerber, Hans-Peter
    Mbow, Brianna
    Whiting, Nancy
    Drachman, Jonathan
    Grewal, Igbal
    Law, Che-Leung
    CANCER RESEARCH, 2009, 69
  • [33] Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells
    T S Lewis
    R S McCormick
    I J Stone
    K Emmerton
    B Mbow
    J Miyamoto
    J G Drachman
    I S Grewal
    C-L Law
    Leukemia, 2011, 25 : 1007 - 1016
  • [34] A MONOCLONAL-ANTIBODY THAT NEUTRALIZES POLIOVIRUS BY CROSS-LINKING VIRIONS
    THOMAS, AAM
    BRIOEN, P
    BOEYE, A
    JOURNAL OF VIROLOGY, 1985, 54 (01) : 7 - 13
  • [35] Proapoptotic signaling activity of the anti-CD40 monoclonal antibody dacetuzumab circumvents multiple oncogenic transformation events and chemosensitizes NHL cells
    Lewis, T. S.
    McCormick, R. S.
    Stone, I. J.
    Emmerton, K.
    Mbow, B.
    Miyamoto, J.
    Drachman, J. G.
    Grewal, I. S.
    Law, C-L
    LEUKEMIA, 2011, 25 (06) : 1007 - 1016
  • [36] Anti-CD40 monoclonal antibody and CpG-ODN synergize in macrophage activation: Implication for cancer immunotherapy
    Buhtoiarov, IN
    Sondel, PM
    Berke, G
    Lum, HE
    Rakhmilevich, AL
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S49 - S49
  • [37] Outcome of Patients With Lupus Nephritis Treated With an Anti-CD40 Monoclonal Antibody According to Kidney Biopsy Features
    Uzzo, Martina
    Schumacher, Helmut
    Steffgen, Juergen
    Deutschel, Simone
    Jayne, David
    Bajema, Ingeborg
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [38] Induction of CD40 expression and enhancement of monoclonal antibody production on murine B cell hybridomas by cross-linking of IgG receptors
    Martin-Lopez, Alicia
    Garcia-Camacho, Francisco
    Belarbi, El Hassan
    Martinez-Escobar, Sergio
    Contreras-Gomez, Antonio
    Molina-Grima, Emilio
    BIOTECHNOLOGY PROGRESS, 2007, 23 (02) : 452 - 457
  • [39] Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model
    Jensen, JN
    Tung, THH
    Mackinnon, SE
    Brenner, MJ
    Hunter, DA
    MICROSURGERY, 2004, 24 (04) : 309 - 315
  • [40] Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody
    Namba, K
    Ogasawara, K
    Kitaichi, N
    Morohashi, T
    Sasamoto, Y
    Kotake, S
    Matsuda, H
    Iwabuchi, K
    Iwabuchi, C
    Ohno, S
    Onoé, K
    JOURNAL OF IMMUNOLOGY, 2000, 165 (06): : 2962 - 2969
12345